These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 22850318

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K, Remer T, Fritsche A, Häring HU, Maser-Gluth C.
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M, Zehnder D, Lepenies J, Petrelli MD, Moore JS, Hughes SV, Cockwell P, Hewison M, Stewart PM.
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M, Delitala G, Mantero F, Stewart PM, Shackleton CH.
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cortisol metabolism in depressed patients and healthy controls.
    Römer B, Lewicka S, Kopf D, Lederbogen F, Hamann B, Gilles M, Schilling C, Onken V, Frankhauser P, Deuschle M.
    Neuroendocrinology; 2009 Jan; 90(3):301-6. PubMed ID: 19713693
    [Abstract] [Full Text] [Related]

  • 12. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
    Morelli V, Polledri E, Mercadante R, Zhukouskaya V, Palmieri S, Beck-Peccoz P, Spada A, Fustinoni S, Chiodini I.
    Endocrine; 2016 Sep; 53(3):809-15. PubMed ID: 26438395
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):37-45. PubMed ID: 16402926
    [Abstract] [Full Text] [Related]

  • 15. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.
    Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E, Wudy SA.
    Steroids; 2006 Jul; 71(7):591-8. PubMed ID: 16616286
    [Abstract] [Full Text] [Related]

  • 18. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C, Martinez-Aguayo A, Baudrand R, Carvajal CA, Aglony M, Garcia H, Padilla O, Kalergis AM, Fardella CE.
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.
    Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, Calhoun DA.
    Am J Hypertens; 2017 May 01; 30(5):518-523. PubMed ID: 28180242
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.